Mydecine Announces Intention to Refile Certain Financial Statements and Applies for Management...

Stockhouse Apr 25 18:45 ET

Mydecine Innovations Group Receives Notice of Allowance From USPTO For MYCO-005 Compound

Mydecine Innovations Group, Inc., (MYCO.CSE) on Monday said it has received the issuance of a Notice of Allowance by the United States Patent and Trademark Office (USPTO) for their MYCO-005 compound.

MT NewswiresDec 18, 2023 07:23 ET

Canadian Securities Exchange Reports October 2023 Performance Figures

Toronto, Ontario--(Newsfile Corp. - November 17, 2023) - The Canadian Securities Exchange ("CSE" or "the Exchange") today announced market statistics for October 2023.October 2023 Operating Statistics

newsfileNov 17, 2023 12:02 ET

Mydecine Innovations Group Provided Q4 2023 Business Update

Mydecine Innovations Group, Inc., (MYCO.CSE) earlier Thursday provided a general update. The company has spent the past few months simplifying its business model, streamline workflow and processes, an

MT NewswiresOct 26, 2023 07:48 ET

Mydecine Innovations Group Brief: Announced Admission to Trading on AQSE Growth Market in London, UK and First Day of Dealings

06:17 AM EDT, 10/10/2023 (MT Newswires) -- Mydecine Innovations Group Brief: Announced Admission to Trading on AQSE Growth Market in London, UK and First Day of Dealings

MT NewswiresOct 10, 2023 06:17 ET